Novel ATR Inhibitor Shows Promise in Children With Tumors ...Middle East

Medscape - News
The novel ataxia telangiectasia–mutated Rad3-related (ATR) inhibitor, ceralasertib, showed some promise in combination with olaparib in pediatric patients with tumors with DNA repair deficiencies. MDedge News

Hence then, the article about novel atr inhibitor shows promise in children with tumors was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel ATR Inhibitor Shows Promise in Children With Tumors )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News